US Lawmakers Call on FDA to Investigate US Clinical Trials That Partner With Chinese Military

“The Chinese Communist Party (CCP) is engaged in genocide of the Uyghur population,” the lawmakers wrote in a letter to FDA Commissioner Robert Califf.

U.S. Rep. John Moolenaar (R-Mich.) on Capitol Hill in Washington on March 28, 2017. Zach Gibson/Getty Images

A bipartisan group of lawmakers is calling on the U.S. Food and Drug Administration (FDA) to ensure that American clinical trials that are run in conjunction with the Chinese military are not aiding the “genocide” of ethnic minorities by the Chinese regime or putting national security at risk.

“The Chinese Communist Party (CCP) is engaged in genocide of the Uyghur population,” the lawmakers wrote in a letter to FDA Commissioner Robert Califf.